Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauber

Showing results (691-700 of 854) with videos related to

Pageof 86
Sort By:
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Neurology and Therapy|September 29, 2024
A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in JapanTakao Takeshima, Akira Yuasa, Yukie Michelle Lloyd, et al.
Scientific Reports|January 25, 2024
Functional neurogenomic responses to acoustic threats, including a heterospecific referential alarm call and its referent, in the auditory forebrain of red-winged blackbirdsN D Antonson, J K Enos, S L Lawson, et al.
Patient Preference and Adherence|May 15, 2025
Patients' Preferences for Attributes of Oral vs Injectable Androgen Deprivation Therapy in Prostate Cancer: A Discrete Choice ExperimentSean P Collins, Agnes Hong, Brett Hauber, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndromeLarry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
The Journal of Biological Chemistry|February 18, 2006
Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA elementAlexander T Prechtel, Jan Chemnitz, Susann Schirmer, et al.
The Patient|January 29, 2016
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid TumorsYi Qian, Jorge Arellano, A Brett Hauber, et al.
BMC Infectious Diseases|July 10, 2026
Heterogeneity of patient preferences for long-acting HIV treatment among people with HIV in KenyaEnrique M Saldarriaga, Brett Hauber, Jacinda Tran, et al.
Neuroscience Letters|April 21, 2016
Shared neural substrates for song discrimination in parental and parasitic songbirdsMatthew I M Louder, Henning U Voss, Thomas J Manna, et al.
Pageof 86

Showing results (691-700 of 854) with videos related to

Sort By:
Pageof 86
The Patient|August 30, 2023
Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold TechniqueJorien Veldwijk, Rachael Lynn DiSantostefano, Ellen Janssen, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Neurology and Therapy|September 29, 2024
A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in JapanTakao Takeshima, Akira Yuasa, Yukie Michelle Lloyd, et al.
Scientific Reports|January 25, 2024
Functional neurogenomic responses to acoustic threats, including a heterospecific referential alarm call and its referent, in the auditory forebrain of red-winged blackbirdsN D Antonson, J K Enos, S L Lawson, et al.
Patient Preference and Adherence|May 15, 2025
Patients' Preferences for Attributes of Oral vs Injectable Androgen Deprivation Therapy in Prostate Cancer: A Discrete Choice ExperimentSean P Collins, Agnes Hong, Brett Hauber, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndromeLarry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
The Journal of Biological Chemistry|February 18, 2006
Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA elementAlexander T Prechtel, Jan Chemnitz, Susann Schirmer, et al.
The Patient|January 29, 2016
Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid TumorsYi Qian, Jorge Arellano, A Brett Hauber, et al.
BMC Infectious Diseases|July 10, 2026
Heterogeneity of patient preferences for long-acting HIV treatment among people with HIV in KenyaEnrique M Saldarriaga, Brett Hauber, Jacinda Tran, et al.
Neuroscience Letters|April 21, 2016
Shared neural substrates for song discrimination in parental and parasitic songbirdsMatthew I M Louder, Henning U Voss, Thomas J Manna, et al.
Pageof 86